Myocardial bioenergetic abnormalities in experimental uremia.

Area of Science:

• Cardiovascular Research
• Metabolic Physiology
• Renal Medicine

Background:

• Cardiac bioenergetics are altered in experimental uremia, indicated by a reduced phosphocreatine (PCr)/adenosine triphosphate (ATP) ratio.
• The temporal progression of these bioenergetic deficits during uremia development requires further investigation.

Purpose of the Study:

• To investigate the progression of cardiac and skeletal muscle bioenergetic changes over time in a rat model of experimental uremia.
• To assess the adaptive mechanisms and energy reserve capacity of the heart at different stages of uremia.

Main Methods:

• A two-stage partial nephrectomy (PNx) model was used in male Wistar rats to induce experimental uremia.
• In vivo cardiac and skeletal muscle bioenergetics were assessed using phosphorus-31 nuclear magnetic resonance ((31)P-NMR) spectroscopy and capillary zone electrophoresis.
• High-energy phosphate nucleotide levels, specifically the PCr/ATP ratio, were quantified.

Main Results:

• Four weeks post-PNx, a significantly lower PCr/ATP ratio was observed in the hearts of uremic rats compared to sham-operated controls.
• At eight weeks post-PNx, the PCr/ATP ratio in uremic hearts showed partial recovery, suggesting adaptation.
• Dobutamine-stressed hearts from uremic rats exhibited a reduced PCr/ATP ratio, indicating diminished energy reserve capacity.
• Similar bioenergetic changes were observed in skeletal muscle, mirroring those in cardiac tissue.

Conclusions:

• Experimental uremia leads to significant alterations in myocardial energetics.
• Skeletal muscle bioenergetics reflect changes in cardiac tissue, suggesting its potential as a surrogate for clinical cardiac NMR investigations.
• These findings provide insights into the progression of cardiac dysfunction in uremia and highlight potential non-invasive diagnostic strategies.